Skip to content
Delayed ~15 min

INBX INHIBRX BIOSCIENCES INC

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Fri 13 Nov 2026 · after market close

What 7 analyst firms say about INHIBRX BIOSCIENCES INC: their latest ratings, price targets and how far the stock is from them. How it works

84.52 USD+4.24 (+5.28%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+146.5%to the avg target 208.33 USD+123.81 USD
Buy 3 · Hold 3 · Sell 0

6 rated views · 7 analyst/firm records · 7 firms

Latest report24 Aug 2026avg report date 29 May
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
  • Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)

Recent analyst activity · last 90 days

Our tracked history has 3 reports on INBX from 3 analyst firms in the last 90 days (7 firms in the past year).

Comparing each firm's latest target with its previous one: 1 has its first observed target in the past year.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
CitigroupUnnamed analystHold18 Sep 2026—
Citizens JMPReni BenjaminHold1 Jul 2026—
H.C. WainwrightRobert BurnsBuy24 Aug 2026245.00 USD
Lifesci CapitalOliver MccammonBuy24 Apr 2026230.00 USD
StifelDara AzarBuy8 Apr 2026150.00 USD
Weiss RatingsUnnamed analyst—11 Sep 2026—
Data feed RESEARCHResearch TeamHold9 Apr 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:09 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.